Emcure Pharma arm developing Omicron specific Covid vaccine
On its mRNA platform, Gennova Biopharmaceuticals, a subsidiary of Pune-based firm Emcure Pharmaceuticals, is developing a Covid-19 vaccine that will target the Omicron variety, which is causing the country’s third coronavirus infection epidemic. The c...
11 February, 2022
Read more
